|
|
The Analysis of Vaccine Market |
LI Min |
Institute of Science and Technology Strategy, Jiangxi Academy of Sciences, Nanchang 330096, China |
|
|
Abstract Vaccine is the most effective weapon for the prevention of the disease, which is the public medical product that everyone can't be separated from and has made great contributions to the health of all mankind. There are about 68 kinds of vaccines in the global market at present and can prevent 34 kinds of diseases. Global vaccine markets maintain steady growth. Vaccine sales increased year by year and the market sales were 29.6 billion dollars in 2015. The top 5 companies, Pfizer, Merck, Sanofi, GSK, Novartis, occupied more than 85% of the market share. A variety of vaccine products had good sales performance. China vaccine markets also grow consistently with a market value of 18.37 billion in 2015. The issued amount of vaccine was 704 million bottles in 2015. The types of vaccine productions are increased and the ability of vaccine research and development is gradually strengthened. The vaccine markets in emerging countries are gradually developing and India performs excellently. The internationalization of Chinese vaccine industry is not as good as India, but it also made a lot of progress. Chinese vaccine industry entering the international market has become an irreversible trend in the future.
|
Received: 07 July 2016
Published: 25 January 2017
|
|
|
|
[1] 高云华, 吴曙霞, 刁天喜. 预防疫苗产业市场的现状与发展趋势. 中国新药杂志, 2008, 17(20):1736-1738. Gao Y H, Wu SH X, Diao T X. The current status and trends of the preventive vaccine market. Chinese Journal of New Drugs, 2008, 17(20):1736-1738.
[2] 王福清, 易静薇, 赵晓嬿, 等. 我国疫苗产业发展现状与展望. 中国生化药物杂志, 2009, 30(4):287-290. Wang F Q, Yi J W, Zhao X Y, et al. The development status and perspective of vaccine industry in China. Chinese Journal of Biochemical Pharmaceutics, 2009, 30(4):287-290.
[3] 丁辉. 生物制药前景广阔, 细分行业各有千秋. 江苏科技信息, 2011, (5):40-42. Ding H. Good prospects for biopharmaceutical industry with merits in each segments. Jiangsu Science and Technology Information, 2011, (5):40-42.
[4] 王永庆. 加快疫苗产业自主发展,确保国家生物安全. 经济界, 2015, (3):6-7. Wang Y Q. Accelerating the development of the vaccine industry, ensuring the safety of national biological. Economic Affairs, 2015, (3):6-7.
[5] Rappuoli R, Aderem A. A 2020 vision for vaccines against HIV, tuberculosis and malaria. Nature, 2011, 473(7348):463-469.
[6] 于盟. 全球疫苗市场综述. 精细与专用化学品, 2015, 23(11):10-12. Yu M. Overview on the global vaccine market. Fine and Specialty Chemicals, 2015, 23(11):10-12.
[7] Kennedy R B, Ovsyannikova I G, Lambert N D, et al. The personal touch:strategies toward personalized vaccines and predicting immune responses to them. Expert Rev Vaccines, 2014, 13(5):657-669.
[8] Delany I, Rappuoli R, Seib K L. Vaccines, reverse vaccinology, and bacterial pathogenesis. Cold Spring Harb Perspect Med, 2013, 3(5):a012476.
[9] 于盟.中印疫苗产业国际化对比. 医药经济报, 2015-05-27(003版). Yu M. International comparison of vaccine industry in China and India. Medicine Economic Report, 2015-95-27(003).
[10] 阿丽塔, 刘晓婷, 孙灵芝. 全球疫苗产业现状与发展趋势. 2011, 20(22):16-18. A L T, Liu X T, Sun L Z. Current status and development trend of global vaccine industry. China Pharmaceuticals, 2011, 20(22):16-18. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|